Device Trial Radar · NCT06248216
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
Last checked: Nov 19, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Dec 4, 2024
Primary completion
Apr 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- University of Maryland, BaltimoreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 8, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 88 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.
Conditions
- Cancer
- Cancer Pain
- Virtual Reality
Interventions
RelievrxDevice
The RelieVRx program is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.
Audio Mp4Other
Audio Mp4 modules ranging from 3-15 minutes with guided meditation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- VR effect on perceived painTime frame: Baseline to end of intervention (4 weeks)
- VR effect on perceived fatigueTime frame: Baseline to end of intervention (4 weeks)
- VR effect on perceived anxietyTime frame: Baseline to end of intervention (4 weeks)
9 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Luana Colloca
Baltimore, Maryland · Recruiting
University of Maryland
Baltimore, Maryland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.